Pasireotide in Cushing's disease.
作者信息
Targher Giovanni
出版信息
N Engl J Med. 2012 May 31;366(22):2134; author reply 2134-5. doi: 10.1056/NEJMc1204078.
PMID:22646646
Abstract
摘要
相似文献
1
Pasireotide in Cushing's disease.帕西瑞肽治疗库欣病
N Engl J Med. 2012 May 31;366(22):2134; author reply 2134-5. doi: 10.1056/NEJMc1204078.
2
Pasireotide in Cushing's disease.帕西瑞肽治疗库欣病
N Engl J Med. 2012 May 31;366(22):2134; author reply 2134-5. doi: 10.1056/NEJMc1204078.
3
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.多受体配体生长抑素类似物帕瑞肽（SOM230）治疗垂体依赖性库欣病：一项多中心II期试验
J Clin Endocrinol Metab. 2009 Jan;94(1):115-22. doi: 10.1210/jc.2008-1008. Epub 2008 Oct 28.
4
Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.帕西瑞肽单药治疗或联合卡麦角林及酮康唑治疗库欣病
N Engl J Med. 2010 May 13;362(19):1846-8. doi: 10.1056/NEJMc1000094.
5
Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial.帕西瑞肽可使尿皮质醇持续降低，并为库欣病患者带来临床益处：一项开放式、开放标签扩展试验的结果
Pituitary. 2015 Oct;18(5):604-12. doi: 10.1007/s11102-014-0618-1.
6
A 12-month phase 3 study of pasireotide in Cushing's disease.一项为期 12 个月的培塞利肽治疗库欣病的 3 期研究。
N Engl J Med. 2012 Mar 8;366(10):914-24. doi: 10.1056/NEJMoa1105743.
7
Medical treatment of Cushing's disease: somatostatin analogues and pasireotide.库欣病的治疗：生长抑素类似物和帕瑞肽。
Neuroendocrinology. 2010;92 Suppl 1:120-4. doi: 10.1159/000314352. Epub 2010 Sep 10.
8
How to manage pasireotide, when using as medical treatment for Cushing's disease.在将帕瑞肽用于库欣病的医学治疗时，应如何进行管理。
Endocrine. 2015 Dec;50(3):526-8. doi: 10.1007/s12020-015-0754-z. Epub 2015 Sep 29.
9
Pasireotide-resistant Refractory Cushing's Disease without Somatostatin Receptor 5 Expression.无生长抑素受体5表达的帕西瑞肽抵抗性难治性库欣病
Intern Med. 2022 Mar 1;61(5):679-685. doi: 10.2169/internalmedicine.6314-20. Epub 2021 Aug 31.
10
A Single-Center 10-Year Experience with Pasireotide in Cushing's Disease: Patients' Characteristics and Outcome.一项关于帕瑞肽治疗库欣病的单中心10年经验：患者特征与结局
Horm Metab Res. 2016 May;48(5):290-8. doi: 10.1055/s-0042-101347. Epub 2016 Apr 29.
引用本文的文献
1
Recent advances in the medical treatment of Cushing's disease.库欣病医学治疗的最新进展。
F1000Prime Rep. 2014 Mar 3;6:18. doi: 10.12703/P6-18. eCollection 2014.
2
Lycopene and beta-carotene induce growth inhibition and proapoptotic effects on ACTH-secreting pituitary adenoma cells.番茄红素和β-胡萝卜素可诱导 ACTH 分泌性垂体腺瘤细胞生长抑制和促凋亡作用。
PLoS One. 2013 May 7;8(5):e62773. doi: 10.1371/journal.pone.0062773. Print 2013.
Zotero 插件